Citation Impact
Citing Papers
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Acute Biological Effects of Simulating the Whole-Body Radiation Dose Distribution from a Solar Particle Event Using a Porcine Model
2011 StandoutNobel
Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma
2020
Intensity-modulated Radiotherapy in the Treatment of Lung Cancer
2012
Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: Controversies, insights, and changing horizons
2014
Hepatocellular carcinoma
2018 Standout
Lung Cancer in Octogenarians
2010
Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing
2008
Guidelines on the radical management of patients with lung cancer
2010
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II Study
2009
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Radiation Dose-Volume Effects in the Esophagus
2010
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
2010 Standout
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
Stereotactic body radiation therapy for oligometastases
2009
Report From the International Atomic Energy Agency (IAEA) Consultants' Meeting on Elective Nodal Irradiation in Lung Cancer: Non–Small-Cell Lung Cancer (NSCLC)
2008
Stereotactic body radiation therapy: a novel treatment modality
2009
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Lung Cancer: Epidemiology, Etiology, and Prevention
2011 Standout
Hepatocellular carcinoma
2021 Standout
Outcomes of stereotactic ablative radiotherapy for central lung tumours: A systematic review
2013
Local Surgical, Ablative, and Radiation Treatment of Metastases
2009
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors
2012
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
2014 Standout
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Liver-Directed Radiotherapy for Hepatocellular Carcinoma
2016
The oligometastatic state—separating truth from wishful thinking
2014
Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease
2016
Lung cancer: current therapies and new targeted treatments
2016 Standout
Phase II Study of Accelerated Hypofractionated Three-Dimensional Conformal Radiotherapy for Stage T1-3 N0 M0 Non-Small Cell Lung Cancer: NCIC CTG BR.25
2014
Radiation Therapy–Related Toxicity (Including Pneumonitis and Fibrosis)
2009
Stereotactic Ablative Radiotherapy for Centrally Located Early Stage Non–Small-Cell Lung Cancer: What We Have Learned
2014
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer
2008
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review
2015
Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular Carcinoma
2013
Cancer and Radiation Therapy: Current Advances and Future Directions
2012 Standout
The role of local therapy in the management of lung and liver oligometastases
2011
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review
2011
Observation of a Dose–Control Relationship for Lung and Liver Tumors After Stereotactic Body Radiation Therapy
2008
Stereotactic Body Radiotherapy (SBRT) for Operable Stage I Non–Small-Cell Lung Cancer: Can SBRT Be Comparable to Surgery?
2010
British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE
2015
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
2012
Universal Survival Curve and Single Fraction Equivalent Dose: Useful Tools in Understanding Potency of Ablative Radiotherapy
2008
The North American Experience with Stereotactic Body Radiation Therapy in Non-small Cell Lung Cancer
2007
Hepatocellular carcinoma
2022 Standout
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
2010 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma
2013
Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage
2017
European Organisation for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung Cancer
2010
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Radiation-induced lung injury. Assessment, management, and prevention.
2008
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
2009
Stereotactic Body Radiation Therapy in Multiple Organ Sites
2007
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
2009 Standout
Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant
2021
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
2014 StandoutNobel
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2—Tumor and Immunological Responses
2012
New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology
2013
Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis of local control, survival and toxicity outcomes
2021
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Strategies for Combining Immunotherapy with Radiation for Anticancer Therapy
2015 StandoutNobel
Emergence of Stereotactic Body Radiation Therapy and Its Impact on Current and Future Clinical Practice
2014
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
Stereotactic Body Radiation Therapy: Scope of the Literature
2011
Works of J. DeLuca being referenced
Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma
2010
Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer
2006
Phase I Trial of Stereotactic Body Radiation Therapy for Primary Hepatocellular Carcinoma
2008
Matched‐pair and propensity score comparisons of outcomes of patients with clinical stage I non–small cell lung cancer treated with resection or stereotactic radiosurgery
2013